(Q36363610)

13 August 2017

title

Lamotrigine augmentation strategy for patients with treatment-resistant depression (English)

1 reference

13 August 2017

1 reference

Rosben L Gutierrez

1

1 reference

13 August 2017

Ruth M McKercher

series ordinal

2

1 reference

13 August 2017

Jason Galea

series ordinal

3

1 reference

13 August 2017

Katrina L Jamison

series ordinal

4

1 reference

13 August 2017

publication date

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

10

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

800-805

1 reference

Treatment algorithms in treatment-resistant depression

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

The multiple facets of treatment-resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

Lamotrigine augmentation in unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

7 January 2021

A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

7 January 2021

Lamotrigine as an augmentation agent in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

7 January 2021

A Double-Blind, Randomized, Placebo-Controlled Trial of Augmentation With Lamotrigine or Placebo in Patients Concomitantly Treated With Fluoxetine for Resistant Major Depressive Episodes

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

7 January 2021

Tricyclic nonresponders: phenomenology and treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

7 January 2021

Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900010324

7 January 2021

10.1017/S1092852900010324

Identifiers

DOI

1 reference

release_pg4ekkwblfc5ba66nn5fpxgixm

13 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pg4ekkwblfc5ba66nn5fpxgixm

24 November 2022

mapped directly with Wikidata item

1 reference